{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:33:42Z","timestamp":1777894422906,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.intimp.2026.116413","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:18:00Z","timestamp":1771636680000},"page":"116413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vericiguat improves CKD-related vascular calcification through the NO\/cGMP\/PKG pathway"],"prefix":"10.1016","volume":"175","author":[{"given":"Chengsi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyingjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yachen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116413_bb0005","doi-asserted-by":"crossref","unstructured":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet (London, England) 395 (10225) (2020) 709\u2013733.","DOI":"10.1016\/S0140-6736(19)32977-0"},{"issue":"10","key":"10.1016\/j.intimp.2026.116413_bb0010","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1681\/ASN.2014070714","article-title":"Cause of death in patients with reduced kidney function","volume":"26","author":"Thompson","year":"2015","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"issue":"3","key":"10.1016\/j.intimp.2026.116413_bb0015","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/ndt\/gfac194","article-title":"Association of coronary artery calcium with adverse cardiovascular outcomes and death in patients with chronic kidney disease: results from the KNOW-CKD","volume":"38","author":"Jung","year":"2023","journal-title":"Nephrol. Dial. Transpl.: Off. Publ. Eur. Dial. Transpl. Assoc.-Eur. Kidney Assoc."},{"issue":"4","key":"10.1016\/j.intimp.2026.116413_bb0020","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/cvr\/cvy010","article-title":"Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness","volume":"114","author":"Durham","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.intimp.2026.116413_bb0025","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.intimp.2026.116413_bb0030","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1093\/cvr\/cvab046","article-title":"Vascular smooth muscle cells in atherosclerosis: time for a re-assessment","volume":"117","author":"Grootaert","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"24","key":"10.1016\/j.intimp.2026.116413_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417129","article-title":"Cells in atherosclerosis: focus on cellular senescence from basic science to clinical practice","volume":"24","author":"Moln\u00e1r","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2026.116413_bb0040","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s40265-021-01496-z","article-title":"Vericiguat: first approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.intimp.2026.116413_bb0045","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1093\/cvr\/cvaa247","article-title":"Vericiguat in worsening heart failure: agonising over, or celebrating, agonism in the VICTORIA trial","volume":"116","author":"Lang","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.116413_bb0050","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s10741-024-10425-7","article-title":"Vericiguat in heart failure with reduced ejection fraction: hope or solid reality?","volume":"29","author":"Correale","year":"2024","journal-title":"Heart Fail. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2026.116413_bb0055","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1038\/s41598-020-62156-y","article-title":"Stimulation of soluble guanylate cyclase improves donor organ function in rat heart transplantation","volume":"10","author":"Benke","year":"2020","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.intimp.2026.116413_bb0060","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jacbts.2021.05.004","article-title":"Implications of Iron deficiency in STEMI patients and in a murine model of myocardial infarction","volume":"6","author":"Inserte","year":"2021","journal-title":"JACC. Basic Transl. Sci."},{"key":"10.1016\/j.intimp.2026.116413_bb0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.trsl.2024.07.005","article-title":"Vericiguat attenuates doxorubicin-induced cardiotoxicity through the PRKG1\/PINK1\/STING axis","volume":"273","author":"Zeng","year":"2024","journal-title":"Transl. Res.: J. Lab. Clin. Med."},{"key":"10.1016\/j.intimp.2026.116413_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122184","article-title":"Vericiguat alleviates ventricular remodeling and arrhythmias in mouse models of myocardial infarction via CaMKII signaling","volume":"334","author":"Chen","year":"2023","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.116413_bb0075","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/ehf2.14802","article-title":"Evaluating haemodynamic changes: vericiguat in patients with heart failure with reduced ejection fraction","volume":"11","author":"Suzuki","year":"2024","journal-title":"ESC Heart Fail."},{"issue":"16","key":"10.1016\/j.intimp.2026.116413_bb0080","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1042\/CS20210259","article-title":"Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling","volume":"135","author":"Feng","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"issue":"1","key":"10.1016\/j.intimp.2026.116413_bb0085","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1038\/s41598-025-88938-w","article-title":"Vericiguat prevents high glucose-mediated impaired vascular smooth muscle cGMP production and vasorelaxation","volume":"15","author":"Polhemus","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116413_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108934","article-title":"Ginsenoside re inhibits PDGF-BB-induced VSMC proliferation via the eNOS\/NO\/cGMP pathway","volume":"115","author":"Gao","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"13","key":"10.1016\/j.intimp.2026.116413_bb0095","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1093\/cvr\/cvad119","article-title":"Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome","volume":"119","author":"Chen","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.116413_bb0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/path.5992","article-title":"Downregulation of HDAC9 by the ketone metabolite \u03b2-hydroxybutyrate suppresses vascular calcification","volume":"258","author":"Lan","year":"2022","journal-title":"J. Pathol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116413_bb0105","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/ndt\/gfg296","article-title":"In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual kidney function than 1,25(OH)2 vitamin D3","volume":"18","author":"Hirata","year":"2003","journal-title":"Nephrol. Dial. Transpl.: Off. Publ. Eur. Dial. Transpl. Assoc.-Eur. Kidney Assoc."},{"issue":"8","key":"10.1016\/j.intimp.2026.116413_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9081047","article-title":"Soluble guanylate cyclase stimulator Vericiguat enhances long-term memory in rats without altering cerebral blood volume","volume":"9","author":"Nelissen","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2026.116413_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121929","article-title":"Vericiguat preserved cardiac function and mitochondrial quality in a rat model of mitral regurgitation","volume":"328","author":"Jungtanasomboon","year":"2023","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.intimp.2026.116413_bb0120","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.3390\/nu7075222","article-title":"Ellagic acid prevents L-NAME-induced hypertension via restoration of eNOS and p47phox expression in rats","volume":"7","author":"Berkban","year":"2015","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.intimp.2026.116413_bb0125","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s10753-016-0409-0","article-title":"The effects of dexamethasone and L-NAME on acute lung injury in rats with lung contusion","volume":"39","author":"Kozan","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2026.116413_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175132","article-title":"Anti-inflammatory, anti-oxidant and cardio-protective properties of novel fluorophenyl benzimidazole in L-NAME-induced hypertensive rats","volume":"929","author":"Iqbal","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116413_bb0135","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1164\/rccm.202305-0889OC","article-title":"Human neutrophils couple nitric oxide production and extracellular trap formation in allergic asthma","volume":"210","author":"Chac\u00f3n","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.intimp.2026.116413_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084225","article-title":"Bee bread ameliorates vascular inflammation and impaired Vasorelaxation in obesity-induced vascular damage rat model: the role of eNOS\/NO\/cGMP-signaling pathway","volume":"22","author":"Othman","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116413_bb0145","article-title":"An herbal preparation ameliorates heart failure with preserved ejection fraction by alleviating microvascular endothelial inflammation and activating NO-cGMP-PKG pathway","volume":"91","author":"Huang","year":"2021","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.intimp.2026.116413_bb0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000346784","article-title":"Phosphate toxicity and vascular mineralization","volume":"180","author":"Razzaque","year":"2013","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.intimp.2026.116413_bb0155","doi-asserted-by":"crossref","unstructured":"Chapter 1: Introduction and definition of CKD-MBD and the development of the guideline statements, Kidney Int. 76113 (2009) S3\u2013S8.","DOI":"10.1038\/ki.2009.189"},{"issue":"1","key":"10.1016\/j.intimp.2026.116413_bb0160","first-page":"1","volume":"7","year":"2017","journal-title":"Kidney Int. Suppl."},{"issue":"4","key":"10.1016\/j.intimp.2026.116413_bb0165","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/cvr\/cvac162","article-title":"Vascular calcification maladaptively participates in acute phosphate homeostasis","volume":"119","author":"Turner","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.intimp.2026.116413_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113947","article-title":"Empagliflozin reduces kidney fibrosis and improves kidney function by alternative macrophage activation in rats with 5\/6-nephrectomy","volume":"156","author":"Lu","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.intimp.2026.116413_bb0175","article-title":"Redox signaling in chronic kidney disease-associated cachexia","volume":"12","author":"Sim\u00f5es","year":"2023","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"8793","key":"10.1016\/j.intimp.2026.116413_bb0180","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic kidney failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.intimp.2026.116413_bb0185","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ekir.2023.01.015","article-title":"Nitric oxide precursors and Dimethylarginines as risk markers for accelerated measured GFR decline in the general population","volume":"8","author":"Rinde","year":"2023","journal-title":"Kidney Int. Rep."},{"issue":"14","key":"10.1016\/j.intimp.2026.116413_bb0190","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.2174\/092986708784567725","article-title":"NO signaling through cGMP in kidney tissue fibrosis and beyond: key pathway and novel therapeutic target","volume":"15","author":"Wang-Rosenke","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2026.116413_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061712","article-title":"The impact of the nitric oxide (NO)\/soluble guanylyl cyclase (sGC) signaling cascade on kidney health and disease: a preclinical perspective","volume":"19","author":"Krishnan","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116413_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121460","article-title":"Soluble guanylate cyclase agonist, isoliquiritigenin attenuates kidney damage and aortic calcification in a rat model of chronic kidney failure","volume":"317","author":"Atteia","year":"2023","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.116413_bb0205","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.yexcr.2015.02.006","article-title":"The sGC activator inhibits the proliferation and migration, promotes the apoptosis of human pulmonary arterial smooth muscle cells via the up regulation of plasminogen activator inhibitor-2","volume":"332","author":"Zhang","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.intimp.2026.116413_bb0210","article-title":"Comparison of sGC activator and sGC stimulator in 5\/6 nephrectomized rats on high-salt-diet","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116413_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052557","article-title":"Targeted delivery of soluble guanylate cyclase (sGC) activator Cinaciguat to kidney mesangial cells via virus-mimetic nanoparticles potentiates anti-fibrotic effects by cGMP-mediated suppression of the TGF-\u03b2 pathway","volume":"22","author":"Fleischmann","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.intimp.2026.116413_bb0220","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/CIRCULATIONAHA.123.066523","article-title":"Reactivation of oxidized soluble guanylate cyclase as a novel treatment strategy to slow progression of calcific aortic valve stenosis: preclinical and randomized clinical trials to assess safety and efficacy","volume":"151","author":"Zhang","year":"2025","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.intimp.2026.116413_bb0225","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1161\/CIRCULATIONAHA.108.827972","article-title":"Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic kidney disease","volume":"119","author":"Aikawa","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.intimp.2026.116413_bb0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCRESAHA.112.281048","article-title":"Smooth muscle cell plasticity: fact or fiction?","volume":"112","author":"Nguyen","year":"2013","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.116413_bb0235","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ki.2010.390","article-title":"Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro","volume":"79","author":"Sage","year":"2011","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.intimp.2026.116413_bb0240","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1161\/ATVBAHA.122.318338","article-title":"Arginase-1 deletion in erythrocytes promotes vascular calcification via enhanced GSNOR (S-Nitrosoglutathione reductase) expression and NO signaling in smooth muscle cells","volume":"42","author":"Gogiraju","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116413_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.200","article-title":"Vascular calcification: molecular mechanisms and therapeutic interventions","volume":"4","author":"Pan","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.intimp.2026.116413_bb0250","doi-asserted-by":"crossref","first-page":"14807","DOI":"10.1038\/ncomms14807","article-title":"Cytoglobin regulates blood pressure and vascular tone through nitric oxide metabolism in the vascular wall","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.intimp.2026.116413_bb0255","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/annrheumdis-2016-210792","article-title":"Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis","volume":"76","author":"Planas-Rigol","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2026.116413_bb0260","first-page":"153","article-title":"Endothelial nitric oxide synthase (eNOS) and the cardiovascular system: in physiology and in disease states","volume":"15","author":"Tran","year":"2022","journal-title":"Am. J. Biomed. Sci. Res."},{"issue":"9","key":"10.1016\/j.intimp.2026.116413_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27092835","article-title":"Interactions among endothelial nitric oxide synthase, cardiovascular system, and nociception during physiological and pathophysiological states","volume":"27","author":"Sarmah","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.intimp.2026.116413_bb0270","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yjmcc.2021.09.005","article-title":"Smooth muscle cell CYB5R3 preserves cardiac and vascular function under chronic hypoxic stress","volume":"162","author":"Durgin","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"18","key":"10.1016\/j.intimp.2026.116413_bb0275","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2174\/1389557519666190730110600","article-title":"Soluble guanylate cyclase stimulators and activators: where are we and where to go?","volume":"19","author":"Xiao","year":"2019","journal-title":"Mini Rev. Med. Chem."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926002572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926002572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:17:09Z","timestamp":1777619829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926002572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":55,"alternative-id":["S1567576926002572"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116413","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vericiguat improves CKD-related vascular calcification through the NO\/cGMP\/PKG pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116413"}}